me likey...
Research, Development and Regulatory
In addition to the FDA clinical trials, PainChek has continued to invest in the development of the core
technology to expand capability into the desktop and embedded platforms for virtual and remote
telehealth pain assessment platforms.
- Forums
- ASX - By Stock
- PCK
- Ann: Half Yearly Report and Accounts
PCK
painchek ltd
Add to My Watchlist
0.00%
!
3.7¢

Ann: Half Yearly Report and Accounts, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.15M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 69758 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 70000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 69758 | 0.037 |
1 | 126171 | 0.036 |
2 | 254851 | 0.035 |
4 | 527450 | 0.034 |
6 | 397606 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 70000 | 1 |
0.036 | 180000 | 3 |
0.037 | 93980 | 2 |
0.038 | 610562 | 3 |
0.040 | 78334 | 3 |
Last trade - 10.02am 16/06/2025 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |